Hypogonadism in men means the body is not producing enough testosterone or normal reproductive function is impaired. A low testosterone result can be an important clue, but it does not explain why testosterone is low.
Primary and secondary hypogonadism originate in different parts of the hormonal system. Primary hypogonadism mainly involves the testes, while secondary hypogonadism involves reduced signalling from the hypothalamus or pituitary gland.
Identifying the type can help guide further testing, clarify whether an underlying cause may be reversible and influence treatment decisions. For men considering testosterone replacement therapy (TRT) in Canada, understanding the cause of low testosterone is an important part of a proper assessment.
Not every case fits neatly into one category. Some men may have mixed causes, while others may have functional suppression related to factors such as obesity, illness or medications.
Topics covered in this article:
Hypogonadism in men refers to impaired testosterone production, reproductive function or both.
A diagnosis should not be based on one low testosterone result alone. In the appropriate clinical context, healthcare providers generally look for:
Symptoms can include low libido, erectile difficulties, reduced energy, changes in muscle mass or body composition and fertility problems.
Because many of these symptoms can also come from other health conditions, hypogonadism should be evaluated using both symptoms and laboratory results rather than a single testosterone number.
Primary hypogonadism occurs when the testes are not producing testosterone adequately despite receiving stimulation from the pituitary gland.
In this situation, the main problem is at the level of the testes.
A typical hormone pattern may include:
LH and FSH may rise because the pituitary is trying to increase stimulation of the testes. If the testes are unable to respond adequately, testosterone can remain low despite these stronger signals.
Primary hypogonadism is also called hypergonadotropic hypogonadism, referring to the higher levels of gonadotropins such as LH and FSH that may accompany the condition.
The exact cause still needs to be identified, since abnormal hormone patterns alone do not explain why testicular function is impaired.
Secondary hypogonadism occurs when the hypothalamus or pituitary does not provide enough hormonal stimulation to the testes.
In this situation, the main problem is with central hormone signalling rather than the testes themselves.
A typical hormone pattern may include:
Secondary hypogonadism is also called hypogonadotropic hypogonadism or central hypogonadism.
Because the testes are not receiving enough stimulation from LH and FSH, testosterone production may fall. The underlying cause can involve the hypothalamus, pituitary gland or factors that suppress this signalling system.
The main difference is where the problem originates.
Main problem | Testes | Pituitary/hypothalamus |
Testosterone | Low | Low |
LH/FSH | Often high | Low or inappropriately normal |
Other name | Hypergonadotropic | Hypogonadotropic/central |
Further evaluation | Testicular causes | Pituitary, prolactin, medications, metabolic causes |
In primary hypogonadism, the pituitary is usually sending strong hormonal signals, but the testes are not responding adequately.
In secondary hypogonadism, the testes may still be capable of producing testosterone, but they are not receiving enough stimulation from the hypothalamus and pituitary.
These hormone patterns can help guide the next steps in evaluation, but they are not a diagnosis by themselves. Symptoms, medical history, repeat testosterone testing and other laboratory results may still be needed to determine the underlying cause.
LH and FSH help distinguish primary from secondary hypogonadism by showing how strongly the pituitary is signalling the testes.
Luteinizing hormone (LH) stimulates the testes to produce testosterone, while follicle-stimulating hormone (FSH) supports sperm production and provides additional information about testicular function.
A simplified interpretation looks like this:
This is why LH and FSH are often checked when testosterone is confirmed to be low. Looking at all three hormones together can help show whether the problem is more likely at the testes or within the hypothalamic-pituitary signalling system.
For a deeper explanation of these hormone patterns, read more about LH and FSH before TRT.
Low testosterone with high LH usually suggests a primary hypogonadal pattern.
In this situation, the pituitary is producing more LH in an attempt to stimulate the testes, but testosterone remains low.
That can suggest the testes are not responding adequately to the hormonal signal.
However, this pattern does not identify the exact cause by itself. Further evaluation may still be needed to determine whether testicular injury, disease, previous treatment or another factor is contributing.
Low testosterone with low or inappropriately normal LH may suggest secondary hypogonadism.
When testosterone is low, the expected response is usually for LH to rise. If LH remains low or within the normal reference range, it may be inappropriately normal for the situation.
This can suggest that signalling from the hypothalamus or pituitary is reduced.
Depending on the clinical picture, further testing may include:
The goal is to identify whether an underlying or potentially reversible cause is contributing to the low testosterone before deciding on treatment.
Primary hypogonadism is caused by problems that impair the testes' ability to produce testosterone normally.
Possible causes include:
The typical hormone pattern is low testosterone with elevated LH and/or FSH, but additional evaluation may be needed to determine the exact cause.
Secondary hypogonadism can develop when the hypothalamus or pituitary does not provide enough hormonal stimulation to the testes.
Possible causes and contributors include:
Some of these causes may be potentially reversible, which is an important distinction from many forms of primary hypogonadism.
For example, obesity, medication effects, illness or hormonal abnormalities can sometimes suppress the hypothalamic-pituitary-gonadal axis without permanent structural damage.
That is why secondary hypogonadism often requires a broader evaluation. A healthcare provider may review medications, prolactin, thyroid function, other pituitary hormones and metabolic health before deciding whether TRT is appropriate.
In some men, addressing the underlying cause may allow testosterone levels to improve, while others may continue to have persistent testosterone deficiency and require further treatment.
Yes. Obesity can contribute to functional suppression of the hypothalamic-pituitary-gonadal axis and may lead to a secondary hypogonadal pattern in some men.
Excess body fat can affect several parts of hormone regulation, including hypothalamic and pituitary signalling. In some men, this can lead to low testosterone with low or inappropriately normal LH, which is more consistent with a secondary pattern.
Obesity does not automatically cause hypogonadism, and not every man with obesity has low testosterone. However, weight-related hormonal suppression can be an important contributor, especially when other metabolic factors are present.
This type of suppression may be potentially reversible. In some men, losing excess weight and improving metabolic health can raise testosterone levels without TRT.
That is why obesity should be considered as part of the overall assessment rather than assuming that low testosterone automatically requires long-term testosterone therapy.
Yes. Persistently elevated prolactin can contribute to secondary hypogonadism by suppressing normal reproductive hormone signalling.
High prolactin can reduce gonadotropin-releasing hormone (GnRH) signalling from the hypothalamus. This may lower LH and FSH stimulation from the pituitary and, in turn, reduce testosterone production.
A typical pattern may include:
Persistent prolactin elevation should be evaluated because the underlying cause may affect the treatment approach.
For a deeper explanation, read more about high prolactin and low testosterone in men.
Yes. Certain medication classes can contribute to secondary hypogonadism by suppressing hormone signalling or increasing prolactin.
Some medications can interfere with the hypothalamic-pituitary-gonadal axis, while others may raise prolactin and indirectly reduce LH, FSH and testosterone.
This does not mean a prescribed medication should be stopped.
Medication review should be clinician-led, especially because stopping or changing treatment without guidance can create other health risks.
If a medication may be contributing to low testosterone, a healthcare provider can assess whether the effect is likely, whether alternatives exist and whether testosterone should be reassessed after any appropriate change.
Mixed hypogonadism means that both primary and secondary factors may be contributing to low testosterone at the same time.
In other words, there may be some impairment at the level of the testes and reduced signalling from the hypothalamus or pituitary.
This can make the hormone pattern less straightforward. LH and FSH may not be clearly high or clearly low, especially when aging, chronic illness, obesity or multiple health conditions are involved.
Because of this, not every man with hypogonadism fits neatly into a primary or secondary category.
Medical history, symptoms, testosterone levels, LH, FSH and other relevant tests may all be needed to understand the overall pattern.
Functional hypogonadism refers to suppressed testosterone production or hormonal signalling without permanent structural damage to the testes, pituitary or hypothalamus.
It is often associated with potentially modifiable factors such as:
In these cases, testosterone may be low because the hypothalamic-pituitary-gonadal axis is being suppressed rather than permanently damaged.
If the underlying factor improves, testosterone levels may also improve in some men.
This is an important distinction before assuming that long-term TRT is automatically necessary. Identifying and addressing potentially reversible contributors can be part of the evaluation first.
Both primary and secondary hypogonadism can affect fertility, but the underlying reason for impaired sperm production may be different.
In primary hypogonadism, the testes themselves may have difficulty producing testosterone, sperm or both. FSH can be particularly useful because elevated FSH may suggest impaired sperm production or testicular function.
In secondary hypogonadism, reduced LH and FSH signalling may limit the stimulation needed for normal testosterone and sperm production.
This distinction matters because some secondary causes may be treatable in ways that preserve or support fertility rather than simply replacing testosterone.
TRT is especially important to discuss in this context because external testosterone can suppress LH and FSH further and reduce sperm production.
Men who are trying to conceive or want to preserve future fertility should therefore discuss those goals before starting TRT. Depending on the situation, further fertility assessment such as semen analysis may also be appropriate.
The cause matters because TRT replaces testosterone but does not necessarily treat the underlying reason testosterone is low.
Before TRT is started, identifying whether the pattern is primary, secondary or mixed can help guide the next steps.
This may include:
The distinction is especially important in secondary hypogonadism because some causes may improve when the underlying problem is addressed.
Fertility also changes the treatment strategy. External testosterone can suppress LH and FSH, which may reduce sperm production.
Because TRT itself alters LH and FSH levels, pre-treatment hormone results are particularly useful diagnostically. Once external testosterone is started, it can become harder to interpret the original hormonal pattern.
The goal is not simply to correct a low testosterone number. It is to understand the cause and choose a treatment approach that fits the individual situation.
No. Primary hypogonadism does not automatically mean TRT is required.
Treatment depends on the full clinical picture, including:
Some men with primary hypogonadism may ultimately be appropriate candidates for TRT, while others may need a different approach.
For example, fertility goals are important because TRT can suppress sperm production. Other health conditions may also affect whether treatment is suitable.
The decision should therefore be individualized rather than based only on the label of primary hypogonadism or one abnormal blood test.
No. Secondary hypogonadism does not always require TRT.
The treatment approach depends on what is causing the reduced hormonal signalling. In some men, the underlying factor may be potentially reversible.
Examples can include:
If one of these factors is contributing, addressing it may allow testosterone levels to improve.
For example, weight loss may raise testosterone in some men with obesity-related functional hypogonadism. A medication review may identify a treatment that is affecting hormone signalling, while persistent high prolactin or a pituitary condition may need its own evaluation and treatment.
This is why secondary hypogonadism should not automatically be treated as a lifelong testosterone deficiency.
In some men, testosterone may recover after the underlying cause is addressed. In others, low testosterone may persist and TRT may still be considered after a full clinical assessment.
Diagnosing the type of hypogonadism usually requires more than a testosterone result alone.
Depending on the clinical picture, testing may include:
The exact workup depends on symptoms, testosterone levels, LH and FSH patterns, medical history and other findings.
The goal is to determine not only whether hypogonadism is present, but what type it is and what may be causing it before deciding on treatment.
Pituitary imaging is not required for every man with low testosterone. It is generally considered when the hormone pattern suggests secondary hypogonadism or when other findings raise concern about a pituitary problem.
Imaging may be considered when there is:
A pituitary MRI can help look for structural causes when the bloodwork and symptoms suggest that the problem may originate centrally rather than at the testes.
The decision should be individualized. An abnormal testosterone or LH result alone does not automatically mean pituitary imaging is needed.
Consider speaking to a healthcare provider if you have symptoms of low testosterone together with abnormal hormone results or other concerns that may need further evaluation.
This is especially important if you have:
A healthcare provider can review testosterone, LH, FSH and other relevant tests together to help determine whether the pattern is primary, secondary, mixed or functional.
Men should not self-diagnose the type of hypogonadism or self-start TRT based on one blood test. Understanding the underlying cause is an important part of choosing the right treatment approach.
Primary hypogonadism mainly involves a problem at the testes, while secondary hypogonadism involves reduced signalling from the hypothalamus or pituitary. Both can result in low testosterone.
Primary hypogonadism occurs when the testes do not produce testosterone adequately despite receiving hormonal stimulation from the pituitary gland.
Secondary hypogonadism occurs when the hypothalamus or pituitary does not provide enough hormonal stimulation to the testes.
Low testosterone with elevated LH often suggests a primary hypogonadal pattern. The pituitary is signalling strongly, but the testes are not responding adequately.
Low testosterone with low LH may suggest secondary hypogonadism, where pituitary or hypothalamic signalling is reduced.
Yes. LH can fall within the laboratory reference range but still be inappropriately normal when testosterone is low because the expected response would usually be for LH to rise.
Possible causes include testicular injury, previous chemotherapy or radiation, certain genetic conditions, testicular disease and other forms of impaired testicular function.
Possible causes include obesity, significant illness, certain medications, elevated prolactin, pituitary or hypothalamic conditions, previous anabolic steroid or testosterone exposure and other endocrine problems.
Yes. Obesity can contribute to functional suppression of the hypothalamic-pituitary-gonadal axis in some men, leading to low testosterone with low or inappropriately normal LH.
Yes. Persistently elevated prolactin can suppress reproductive hormone signalling, which may reduce LH, FSH and testosterone.
Yes. Certain medication classes can suppress hormonal signalling or raise prolactin. Medication changes should always be clinician-led.
Functional hypogonadism refers to reduced testosterone production or signalling without permanent structural damage. It can be associated with factors such as obesity, illness or medication effects.
Mixed hypogonadism means both primary and secondary factors may be contributing to low testosterone at the same time.
Sometimes. If the cause is related to obesity, medication effects, illness, elevated prolactin or another treatable factor, testosterone may improve after the underlying issue is addressed.
It depends on the cause. Some forms of testicular dysfunction are permanent, while others may improve if the underlying problem is temporary or treatable.
It can. Both primary and secondary hypogonadism may affect sperm production, although the mechanism and treatment options can differ.
Not always. TRT may be appropriate for some men with confirmed symptomatic testosterone deficiency, but treatment depends on symptoms, fertility goals, medical history and other clinical factors.
Not always. Some causes may be reversible, so the underlying problem should be evaluated before assuming long-term TRT is necessary.
LH and FSH help show whether low testosterone is more likely related to impaired testicular function or reduced signalling from the pituitary or hypothalamus.
Testing may include repeat morning testosterone, LH, FSH, prolactin, free testosterone or SHBG when indicated, thyroid testing and other pituitary hormones. Imaging may be considered when a pituitary cause is suspected.